Messenger RNA (mRNA)‐based therapies offer great promise for the treatment of a variety
of diseases. In 2020, two FDA approvals of mRNA‐based vaccines have elevated mRNA …

The advent of genome editing has transformed the therapeutic landscape for several
debilitating diseases, and the clinical outlook for gene therapeutics has never been more …

Many emerging therapies rely on the delivery of biological cargo into the cytosol.
Nanoparticle delivery systems hold great potential to deliver these therapeutics but are …

Using nanoparticles to deliver drugs to cells has the potential to revolutionize the treatment
of many diseases, including HIV, cancer, and diabetes. One of the major challenges facing …

This paper provides a third update to the review of reversible deactivation radical
polymerization (RDRP) achieved with thiocarbonylthio compounds (ZC (= S) SR) by a …

Forty years after the first reports on stimuli-responsive phase transitions in synthetic
hydrogels, the first medicines based on responsive components are approaching the …

Hydrogel nanoparticles have gained considerable attention in recent years as one of the
most promising nanoparticulate drug delivery systems owing to their unique potentials via …

Development of effective therapies to control oral biofilms is challenging, as topically
introduced agents must avoid rapid clearance from biofilm–tooth interfaces while targeting …

Nanocarriers have revolutionized drug delivery practices over the past couple of decades,
primarily due to the advances in materials chemistry, nanotechnology and nanomedicine …

Reversible addition fragmentation chain transfer (RAFT) polymerization has made a huge
impact in macromolecular design. The first block copolymers were described early on …